Remote Tailored Interventions Increased Colonoscopy Screening Despite Cost Barriers
the Cancer Therapy Advisor take:
Remote tailored intervention (TeleCARE) was associated with increased colonoscopy uptake among at-risk relatives of patients with colorectal cancer, according to a study published online in the journal Cancer Epidemiology, Biomarkers & Prevention.
Participants in the study included family members of patients with colorectal cancer who were not up-to-date with colonoscopy screening. The participants were then randomly assigned to one of two groups: TeleCARE (N=232) or an educational brochure (N=249).
Results showed that 42.7% of participants in the TeleCARE intent-to-treat analysis had a medically-verified colonoscopy, compared to 24.1% of participants in the educational brochure group (OR = 2.37; 95% CI: 1.59, 3.52). Cost was identified as a barrier for the majority of both experimental cohorts (TeleCARE=62.5% and educational brochure=57.0%). Individuals in the TeleCARE group not affected by the cost barrier were four times as likely to have a colonoscopy compared to those in the educational brochure group (OR = 3.66; 95% CI: 1.85, 7.24).
Overall, the participants in the TeleCARE group were almost twice as likely to have a colonoscopy compared to their counterparts (OR = 1.99; 95% CI: 1.12, 3.52).
The study suggests that remote interventions could be an effective means of increasing colonoscopy screening regardless of cost barriers.
Remote tailored intervention (TeleCARE) was associated with increased colonoscopy uptake among at-risk relatives for colorectal cancer.
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Metastatic Prostate Cancer Responds to Novel Radiation Therapy
- Clinical Applications of Liquid Biopsies in Cancer
- Two-Drug Combination Superior to Sunitinib in Patients With Untreated Advanced Renal Cell Carcinoma
- Radical Prostatectomy Compared With Watchful Waiting in Localized Prostate Cancer
- Immunotherapy in Glioblastoma: Peaks and Pits
- Treatment Guidelines in Cancer: Assessing Industry Influence on Recommendations
- American Society of Breast Surgeons Recommends Genetic Testing for All Patients With Breast Cancer
- No Benefit Seen From HSCT in Hypodiploid B-ALL
- Patients With CP-CML Deemed Less Likely to Continue Taking Generic Imatinib
- Opinion: Understanding the FDA's Take on Cannabidiol